Nuvalent, Inc..
NUVL.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Nuvalent, Inc. is a biopharmaceutical company focused on developing precisely targeted therapies for cancers. They are developing a pipeline of kinase inhibitors targeting specific mutations and pathways in cancer cells. Their research and development efforts are centered on creating novel therapies...Show More
Better Health for All
0
No evidence available to assess Nuvalent, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
Nuvalent, Inc. is a biopharmaceutical company focused on developing cancer therapies. The ethical value 'Fair Money & Economic Opportunity' is specifically designed to assess financial institutions on activities related to lending, insurance, money movement, and storage. As Nuvalent, Inc. does not operate in the financial services sector, the provided articles do not contain any relevant evidence to score the company against the specified KPIs, which are tailored for financial institutions.
1
Therefore, all KPIs are omitted.
Fair Pay & Worker Respect
0
Nuvalent's CEO-to-median employee pay ratio was 25:1 in both 2023 and 2024.
1
The CEO's total compensation was $17,279,869, while the median employee's annual total compensation was $688,370.
2
This ratio is significantly lower than the average S&P 500 company ratio of 268:1.
3
However, employee engagement, as indicated by an overall Glassdoor rating of 2.4 out of 5 (equivalent to 48/100) and only 36% of employees recommending the company to a friend, suggests low staff morale.
4
Employee reviews highlight concerns about management, communication, low pay, lack of overtime compensation, and a toxic work environment with mind-numbing tasks and burnout.
5
Fair Trade & Ethical Sourcing
0
No information related to Nuvalent, Inc.'s fair trade and ethical sourcing practices, supplier audits, child/forced labor incidents, supply chain traceability, remediation speed, ethical clause coverage in contracts, materials risk index, or supplier diversity spend was found in the provided articles.
1
Honest & Fair Business
-20
Nuvalent has a comprehensive Code of Business Conduct and Ethics, adopted in December 2024, which applies to all directors, officers, and employees.
1
The company maintains a whistleblower hotline, accessible via a third-party managed website and phone number, allowing for confidential and anonymous reporting directly to the Compliance Officer and Audit Committee.
2
The Code explicitly states a non-retaliation policy for those reporting violations.
3
The company also has an anti-corruption policy prohibiting bribes, kickbacks, and other improper payments,
4
but there is no evidence of training frequency or effectiveness metrics for this policy. The board has determined that all directors, except for two, are independent under Nasdaq rules,
5
indicating approximately 75% of the board is conflict-free. The company has adopted a clawback policy for incentive-based compensation in the event of an accounting restatement,
6
and no formal restatements have been reported.
7
KPMG LLP has served as the independent registered public accounting firm since 2020, with audit fees of $1,238,750 in 2023 and $535,000 in 2022.
8
All audit and non-audit services require pre-approval by the audit committee.
9
There is no information regarding regulatory fines, transparency index scores, ESG controversy scores, complaint resolution times, audit coverage percentage, or the extent of third-party verification of ethical claims.
Kind to Animals
0
Nuvalent, Inc. conducts animal testing using rats and mice to assess the safety of its product candidates, NVL-520 and NVL-655, as evidenced by preclinical studies including mouse xenograft and rat brain penetration studies.
1
However, the provided articles do not contain specific quantitative data or details for any of the defined KPIs, such as the volume of animals tested, the company's animal testing policy, the extent of alternative testing methods employed, or any certifications or initiatives related to animal welfare.
2
Therefore, all KPIs are omitted due to a lack of specific, concrete evidence.
No War, No Weapons
0
No evidence available to assess Nuvalent, Inc. on No War, No Weapons.
Planet-Friendly Business
0
No evidence available to assess Nuvalent, Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No information regarding Nuvalent, Inc.'s respect for cultures and communities, or any related metrics such as partnerships, community investment, cultural incident protocols, or local employment, was found in the provided articles.
1
The articles focus exclusively on the company's oncology drug pipeline, clinical trials, and investor relations.
Safe & Smart Tech
0
Nuvalent provides users with standard controls over their personal data, allowing them to update or correct information and opt out of marketing communications.
1
The company states it is subject to and aims to comply with various privacy and data security laws, including HIPAA, CCPA, CPRA, and GDPR, and acknowledges extensive regulations by authorities like the FDA and EMA.
2
The company has developed and implemented a cybersecurity risk management program based on the National Institute of Standards and Technology Cybersecurity Framework (NIST CSF), which includes an incident response plan.
3
The board's audit committee oversees cybersecurity risks, receiving annual reports from management and updates on material incidents.
4
The company uses external service providers to assess and test its security controls and provides cybersecurity awareness training to employees, incident response personnel, and senior management.
5
A third-party risk management process is in place for service providers, suppliers, and vendors.
6
The company has a compliance hotline and an online reporting option for suspected violations, with a no-retaliation policy for reporters.
7
Zero Waste & Sustainable Products
0
No specific, concrete data points were found in the provided articles for Nuvalent, Inc. regarding waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging to product ratio, waste reduction targets, supplier waste requirements, or customer waste education.
1